Overview

Study to Assess the Efficacy and Safety of "Pílulas de Lussen®" Compared to the Pyridium® in the Symptomatic Control of Dysuria

Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Clinical Study, prospective, comparative, randomized, double-dummy entry with random from a total of 80 patients, 40 patients will receive the test medication (Pílulas de Lussen®) plus placebo and 40 patients will receive the comparative (Pyridium®) plus placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Laboratorios Osorio de Moraes Ltda.